BioCentury | Jun 6, 2011
Clinical News

BI 661051: Phase I started

...began a double-blind, placebo-controlled, German Phase I trial to compare 2 to 350 mg oral BI 661051...
...Nov. 16, 2009). Evotec AG (Xetra:EVT), Hamburg, Germany Boehringer Ingelheim GmbH , Ingelheim, Germany Product: BI 661051...
Items per page:
1 - 1 of 1